NEW YORK, April 7, 2022 /PRNewswire/ -- The Global Infertility Treatment Market is expected to clock US$ ~3.98 billion by 2031 owing to changing lifestyles and the rising prevalence of infertility in both genders.
Various fertility chain clinics are implementing strategies such as acquisitions to expand their geographical footprint and strengthen R&D activities. This factor is expected to boost the infertility treatment market growth.
For instance, in July 2020, The Fertility Partnership (UK) signed an agreement to acquire VivaNeo GmbH from Waterland Private Equity. The Fertility Partnership ("TFP") is one of the leading European providers of fertility services, ultrasound pregnancy scans, and hormone treatments with 10 fertility clinics in the U.K and Poland.
Whereas, VivaNeo is one of the leading European providers of fertility services with 9 clinics supported by 5 satellite clinics across Germany, Austria, Denmark, and the Netherlands.
The partnership is aimed to improve patient experience and success rates through broader investment in research and technology.
The global infertility treatment market has been analyzed from five different perspectives–Type, Procedure Type, Gender Type, End User, and Region.
Get a Sample PDF Brochure: https://growthplusreports.com/inquiry/request-sample/infertility-treatment-market/7652
Excerpts from 'Competitive Landscape
The prominent players operating in the global infertility treatment market are:
- Esco Micro Pte Ltd
- IVFtech ApS
- Fujifilm Irvine Scientific
- Rocket Medical plc
- Zeiss Microscopy
- Somatex Medical Technologies GmbH
- Cooper Surgical Fertility & Genomic Solutions
- Genea Limited
- among others
Excerpts from 'By Procedure Type Segmentation'
The global infertility treatment market has been segmented majorly into four distinct categories depending on procedure type; viz.
- Assisted reproductive technology
- Artificial insemination
- Fertility surgery
The assisted reproductive technology segment dominated the market with the largest share owing to its greater success rate and favorable reimbursement policies. The assisted reproductive technology procedure is further categorized into in vitro fertilization, intracytoplasmic sperm injection, gamete intrafallopian transfer (GIFT), and others (zygote intrafallopian transfer (ZIFT), frozen embryo transfer (FET) etc.).
Inquire Before Buying Report: https://growthplusreports.com/inquiry/before-buying/infertility-treatment-market/7652
Excerpts from 'By Region Segmentation'
The global infertility treatment market has been segmented into
- North America
- Asia Pacific
- Rest of the World (RoW).
North America is expected to command the largest share of the global infertility treatment market in 2020, followed by Asia Pacific, Europe, and Rest of the World (RoW). Factors such as favorable reimbursement policies, presence of large number of fertility clinics, and greater presence of the prominent players are attributed to the large share of the region in the global market.
Table of Contents
- Market Ecosystem
- Geographic Scope
- Timeline Under Consideration
- Historical Years – 2018 & 2019
- Base Year – 2020
- Forecasted Years – 2021 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
Check out more related studies published by Growth Plus Reports:
Bioinformatics Market by Products & Services (Bioinformatics Platforms, Knowledge Management Tools, and Bioinformatics Services), Applications (Genomics, Proteomics, Metabolomics, Transcriptomics, and Drug Development), End User (Medical Biotechnology, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, and Forensic Biotechnology) – Global Outlook & Forecast 2021-2031
Molecular Diagnostics Market by Product & Services [Systems & Instruments, Assay Reagents & Kits, and Software & Service], Technology [Polymerase Chain Reaction (PCR), DNA Sequencing & Next-Generation Sequencing (NGS), In Situ Hybridization, and Microarrays], Application [Infectious disease, Oncology, Pharmacogenomics, Genetic Testing], End User [Hospitals, Academic Institutes & Research Centers
Biomarkers Market by Offering [Consumables, Services, and Software], Type [Safety Biomarkers, Efficacy Biomarkers and Validation Biomarkers], Application [Diagnostics, Drug Discovery, and Development, and Personalized Medicine], Disease Indication [Cancer, Cardiovascular Diseases, Neurological Diseases, and Immunological Diseases] – Global Outlook & Forecast 2021-2031
Cardiac Safety Services Market by Type (Standalone and Integrated), Services (Cardiac Imaging, ECG/Holter Measurement, Blood Pressure Measurement and Thorough QT Study), End User (Pharmaceutical Companies and Contract Research Organizations (CROs)) – Global Outlook & Forecast 2021-2031
Genetic Testing Market by Testing Type [Prenatal & Newborn Testing, Diagnostic Testing, Carrier Testing, Predictive & Presymptomatic Testing, and Pharmacogenomic Testing], Technology [Cytogenetic Testing, Biochemical Testing, and Molecular Testing] – Global Outlook & Forecast 2021-2031
Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary and primary research, market modelling and forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
SOURCE Growth Plus Reports